RNA-seq may be a new diagnostic method when RARA rearrangements are failed to be identified by conventional methods, because of the obvious transcriptomic difference between APL with FIP1L1::RARA and myeloid neoplasms. This evidence concerns the gene FIP1L1 and myeloid neoplasm.